Trials / Withdrawn
WithdrawnNCT00759083
Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients
Bivalirudin PCI Registry in HIT/HITTS Patients
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The Medicines Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To monitor the frequency of the development of thrombocytopenia in patients with Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome receiving bivalirudin during Percutaneous Coronary Intervention
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bivalirudin | Bivalirudin; 0.75mg/kg/h IV bolus followed immediately by 1.75 mg/kg/h infusion for the duration of the procedure |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-09-01
- Completion
- 2010-05-10
- First posted
- 2008-09-25
- Last updated
- 2020-10-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00759083. Inclusion in this directory is not an endorsement.